4.4 Article

Transforming growth factor-beta induces loss of epithelial character and smooth muscle cell differentiation in epicardial cells

期刊

DEVELOPMENTAL DYNAMICS
卷 235, 期 1, 页码 82-93

出版社

WILEY
DOI: 10.1002/dvdy.20629

关键词

development; chick; epicardium; epithelial-mesenchymal transformation; smooth muscle; transforming growth factor beta receptors

资金

  1. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052922, P01HL067105] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER
  3. NHLBI NIH HHS [P01 HL067105-019001, R01 HL052922-10, HL67105, R01 HL052922, P01 HL067105-010002, P01 HL067105] Funding Source: Medline
  4. NIGMS NIH HHS [5 T32 GM07347] Funding Source: Medline

向作者/读者索取更多资源

During embryogenesis, epicardial cells undergo epithelial-mesenchymal transformation (EMT), invade the myocardium, and differentiate into components of the coronary vasculature, including smooth muscle cells. We tested the hypothesis that transforming growth factor-beta (TGF beta) stimulates EMT and smooth muscle differentiation of epicardial cells. In epicardial explants, TGF beta 1 and TGF beta 2 induce loss of epithelial morphology, cytokeratin, and membrane-associated Zonula Occludens-1 and increase the smooth muscle markers calponin and caldesmon. Inhibition of activin receptor-like kinase (ALK) 5 blocks these effects, whereas constitutively active (ca) ALK5 increases cell invasion by 42%. Overexpression of Smad 3 did not mimic the effects of caALK5. Inhibition of p160 rho kinase or p38 MAP kinase prevented the loss of epithelial morphology in response to TGF beta, whereas only inhibition of p160 rho kinase blocked TGF beta-stimulated caldesmon expression. These data demonstrate that TGF beta stimulates loss of epithelial character and smooth muscle differentiation in epicardial cells by means of a mechanism that requires ALK5 and p160 rho kinase.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据